The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found that people who stopped taking the medication regained much of that weight within a year.
Medtronic wins pulsed field ablation CE mark, teeing up 2-front challenge to Boston Scientific
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Medtronic received a CE mark
November 22, 2023